Epigral share news, announcements and annual reports
NSE: EPIGRALBSE: 543332Chemicals & PetrochemicalsSmall Cap
Epigral Limited · Formerly Meghmani Finechem · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2021
Last close ₹902.40up ₹5.50 (0.61%)BSE ₹904.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹896.90.
28 Oct: open ₹903.00, high ₹924.00, low ₹883.80
52-week range of traded prices to 28 Oct 2026
₹807.00Low, 30 Mar 2026₹1,729.90High, 29 Oct 2025
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,893 Cr807th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 14.36
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.75
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.55%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 20,43846.2% delivered
Epigral has 420 announcements on record, routine notices left out; 4 in the 30 days to 29 Oct 2026, the latest on 28 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Epigral quarterly results
Nov2Mon
The board meets on 2 Nov 2026 to consider financial results
Notice filed 26 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Epigral annual reports, presentations and earnings calls
The company's own documents, latest first.Epigral financials, year by year
Annual reports6
- Annual report, year to Mar 202615 May 2026
- Annual report, year to Mar 20255 Jun 2025
- Annual report, year to Mar 202415 Jun 2024
- Annual report, year to Mar 20233 Jun 2023, a zip file
- Annual report, year to Mar 20223 Jun 2022, a zip file
1 earlier report
- Annual report, year to Mar 202127 Aug 2021, a zip file
Investor presentations31
- Investor Presentation27 Jul 2026
- Investor Presentation2 May 2026
- Investor Presentation30 Jan 2026
- Investor Presentation10 Nov 2025
- Investor Presentation2 Aug 2025
26 earlier presentations
- Investor Presentation5 May 2025
- Investor Presentation27 Jan 2025
- Investor Presentation24 Jul 2024
- Investor Presentation22 Apr 2024
- Investor Presentation24 Jan 2024
- Investor Presentation6 Nov 2023
- Investor Presentation29 Sep 2023
- Investor Presentation16 Aug 2023
- Investor Presentation5 Aug 2023
- Corporate Presentation4 May 2023
- Investor Presentation25 Apr 2023
- Investor Presentation24 Jan 2023
- Investor Presentation19 Jan 2023
- Investor Presentation20 Oct 2022
- Investor Presentation8 Aug 2022
- Earnings Presentation of Q1 FY23.21 Jul 2022
- Investor Presentation7 Jun 2022
- Meghmani Finechem Limited submits herewith revised Earnings Presentation for audited Financial Results of Q4 & FY22.28 Apr 2022
- Investor Presentation25 Apr 2022
- Investor Presentation24 Jan 2022
- Investor Presentation16 Nov 2021
- Investor Presentation15 Nov 2021
- We are enclosing herewith a copy of Corporate Announcement Presentation of theCompany for information of members.The above presentation is also being placed on the website of the Company atwww .meghmanifinechem.corn.11 Nov 2021
- Investor Presentation26 Oct 2021
- Investor Presentation20 Aug 2021
- Investor Presentation18 Aug 2021
Earnings calls38
- Transcript30 Jul 2026
- Link of Recording27 Jul 2026
- Transcript6 May 2026
- Link of Recording3 May 2026
- Epigral Limited submits Transcript of Conference Call held on Friday, 30th January, 2026 for Q3 FY26 Results.3 Feb 2026
33 earlier call documents
- Link of Recording31 Jan 2026
- Transcript13 Nov 2025
- Link of Recording10 Nov 2025
- Transcript6 Aug 2025
- Link of Recording4 Aug 2025
- Transcript8 May 2025
- Link of Recording5 May 2025
- Transcript30 Jan 2025
- Link of Recording27 Jan 2025
- Transcript14 Nov 2024
- Link of Recording11 Nov 2024
- Transcript26 Jul 2024
- Link of Recording24 Jul 2024
- Transcript26 Apr 2024
- Link of Recording22 Apr 2024
- Transcript25 Jan 2024
- Link of Recording24 Jan 2024
- Transcript9 Nov 2023
- Link of Recording6 Nov 2023
- Transcript11 Aug 2023
- Link of Recording7 Aug 2023
- Transcript28 Apr 2023
- Link of Recording26 Apr 2023
- Transcript23 Jan 2023
- Link of Recording20 Jan 2023
- Q2 FY23 Written Transcript of Analysts/Institutional Investor Meet/Con. Call.22 Oct 2022
- Audio Recording of Earnings Conf. Call pertaining Q2 FY23.21 Oct 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call held on 21.07.2022.25 Jul 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call22 Jul 2022
- We submit herewith the revised link to the audio recording of the Earnings Conference Call pertaining to Q4 & FY22 Audited Standalone and Consolidated Financial Results of the Company.28 Apr 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call28 Apr 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call26 Apr 2022
- Transcript16 Nov 2021
Epigral share news and announcements
Newest first. Page 1 of 9.
Oct 2026
26 Oct · Board meeting
21 Oct · Analysts
13 Oct · Analysts
Sep 2026
Aug 2026
31 Aug · Analysts
18 Aug · Analysts
7 Aug · Analysts
Jul 2026
27 Jul · Results
22 Jul · Legal
The exchange asked on 21 Jul 2026
14 Jul · Rating
7 Jul · General Updates
Jun 2026
8 Jun · Meeting
3 Jun · Rating
May 2026
18 May · Analysts
15 May · General Updates
15 May · Meeting
14 May · Corporate action
12 May · Analysts
6 May · Analysts
2 May · Results
Apr 2026
17 Apr · Meeting
16 Apr · General Updates
9 Apr · Analysts
9 Apr · Analysts
7 Apr · Analysts
4 Apr · Analysts
Mar 2026
Feb 2026
Jan 2026
30 Jan · Board meeting
30 Jan · Results
20 Jan · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 27 Jul 2026Resultsdown 0.49%−1.5 pts vs Nifty 500market median −0.7% · five sessions −6.4% (−8.8 pts vs Nifty 500) · volume 5.1× usual · delivery −31.5 pts against usual · The announcement
- 15 Jul 2026Credit ratingup 0.41%+0.1 pts vs Nifty 500market median 0.0% · five sessions +11.1% (+10.4 pts vs Nifty 500) · volume 0.3× usual · delivery −8.8 pts against usual · The announcement
- 4 Jun 2026Credit ratingup 3.64%+3.4 pts vs Nifty 500market median 0.0% · five sessions −1.5% (−0.5 pts vs Nifty 500) · volume 0.7× usual · delivery +12.5 pts against usual · The announcement
- 4 May 2026Resultsup 9.30%+8.7 pts vs Nifty 500market median −0.7% · five sessions +9.2% (+7.3 pts vs Nifty 500) · volume 10.1× usual · delivery −31.7 pts against usual · The announcement
- 30 Jan 2026Resultsup 1.32%+1.6 pts vs Nifty 500market median −0.7% · five sessions −0.3% (−2.0 pts vs Nifty 500) · volume 3.9× usual · delivery −11.0 pts against usual · The announcement
- 11 Nov 2025Resultsdown 2.42%−2.8 pts vs Nifty 500market median −0.7% · five sessions −1.0% (−2.5 pts vs Nifty 500) · volume 7.2× usual · delivery −3.1 pts against usual · The announcement
- 4 Sep 2025Board or managers changeddown 1.64%−1.4 pts vs Nifty 500market median 0.0% · five sessions −1.0% (−1.9 pts vs Nifty 500) · volume 0.6× usual · delivery +11.6 pts against usual · The announcement
- 4 Aug 2025Resultsdown 6.49%−7.3 pts vs Nifty 500market median −0.7% · five sessions −6.4% (−5.3 pts vs Nifty 500) · volume 2.4× usual · delivery −15.8 pts against usual · The announcement
- 5 May 2025Resultsup 0.95%+0.1 pts vs Nifty 500market median −0.7% · five sessions −0.6% (+0.9 pts vs Nifty 500) · volume 8.4× usual · delivery −22.1 pts against usual · The announcement
- 5 May 2025Dividendup 0.95%+0.1 pts vs Nifty 500market median 0.0% · five sessions −0.6% (+0.9 pts vs Nifty 500) · volume 8.4× usual · delivery −22.1 pts against usual · The announcement
18 earlier announcements
- 7 Mar 2025Credit ratingup 5.86%+5.9 pts vs Nifty 500market median 0.0% · five sessions +2.8% (+4.2 pts vs Nifty 500) · volume 1.3× usual · delivery +6.8 pts against usual · The announcement
- 28 Feb 2025Board or managers changeddown 1.03%+1.1 pts vs Nifty 500market median 0.0% · five sessions +8.2% (+7.5 pts vs Nifty 500) · volume 0.8× usual · delivery +14.0 pts against usual · The announcement
- 27 Jan 2025Dividendup 5.71%+7.6 pts vs Nifty 500market median 0.0% · five sessions +9.2% (+7.9 pts vs Nifty 500) · volume 6.8× usual · delivery −25.7 pts against usual · The announcement
- 18 Dec 2024Credit ratingdown 1.57%−0.9 pts vs Nifty 500market median 0.0% · five sessions −7.3% (−4.3 pts vs Nifty 500) · volume 1.6× usual · delivery +7.4 pts against usual · The announcement
- 11 Nov 2024Resultsdown 0.02%+0.2 pts vs Nifty 500market median −0.7% · five sessions −6.2% (−2.9 pts vs Nifty 500) · volume 5.0× usual · delivery −10.4 pts against usual · The announcement
- 24 Jul 2024Resultsup 12.81%+12.6 pts vs Nifty 500market median −0.7% · five sessions +19.2% (+16.7 pts vs Nifty 500) · volume 10.3× usual · delivery −22.3 pts against usual · The announcement
- 22 Apr 2024Dividendup 6.00%+5.1 pts vs Nifty 500market median 0.0% · five sessions −0.9% (−3.2 pts vs Nifty 500) · volume 2.5× usual · delivery −15.0 pts against usual · The announcement
- 30 Jan 2024Credit ratingdown 0.51%+0.2 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−3.0 pts vs Nifty 500) · volume 0.6× usual · delivery +5.8 pts against usual · The announcement
- 24 Jan 2024Resultsdown 1.08%−2.4 pts vs Nifty 500market median −0.7% · five sessions +6.9% (+3.8 pts vs Nifty 500) · volume 1.3× usual · delivery −17.9 pts against usual · The announcement
- 1 Dec 2023Credit ratingup 0.17%−0.5 pts vs Nifty 500market median 0.0% · five sessions +2.7% (−1.3 pts vs Nifty 500) · volume 1.5× usual · delivery +6.8 pts against usual · The announcement
- 6 Nov 2023Resultsup 3.54%+2.6 pts vs Nifty 500market median −0.7% · five sessions +1.0% (−0.5 pts vs Nifty 500) · volume 3.0× usual · delivery −20.6 pts against usual · The announcement
- 7 Aug 2023Resultsdown 4.44%−4.8 pts vs Nifty 500market median −0.7% · five sessions −4.7% (−4.5 pts vs Nifty 500) · volume 4.0× usual · The announcement
- 25 Apr 2023Dividenddown 5.58%−5.8 pts vs Nifty 500market median 0.0% · five sessions −10.2% (−12.6 pts vs Nifty 500) · volume 3.9× usual · The announcement
- 19 Jan 2023Dividenddown 4.43%−4.1 pts vs Nifty 500market median 0.0% · five sessions −13.8% (−11.9 pts vs Nifty 500) · volume 2.5× usual · The announcement
- 9 Dec 2022Credit ratingup 0.24%+0.9 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−0.9 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 20 Oct 2022Resultsdown 5.39%−5.7 pts vs Nifty 500market median −0.7% · five sessions −9.0% (−10.1 pts vs Nifty 500) · volume 2.3× usual · The announcement
- 24 Jan 2022Resultsdown 4.33%−1.2 pts vs Nifty 500market median −0.7% · five sessions +0.6% (+2.3 pts vs Nifty 500) · volume 2.4× usual · The announcement
- 2 Dec 2021Credit ratingup 5.00%+3.7 pts vs Nifty 500market median 0.0% · five sessions +13.2% (+11.2 pts vs Nifty 500) · volume 0.2× usual · The announcement
Epigral results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.